VictoryShares US Discovery Enhanced Volatility Wtd ETF CSF 深 沪
等待开盘 07-18 09:30:00 美东时间
51.03
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 51.03
- 总市值 2551.50万
- 52周最高 60.2845
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 48.0355
- 委 比 0.00%
- 总股本 50.00万
- 历史最高 63.1812
- 量 比 0
- 振 幅 0.00%
- 历史最低 23.3868
- 每 手 1
- 风险率 2.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多港股概念追踪 | 新增商保创新药目录！2025医保目录调整启动 创新药将迎历史性拐点？(附概念股)
中邮证券认为，创新药即使短期震荡亦属正常，仍坚定看好2年-3年维度的创新药行情。
07-14 07:39
Plus Therapeutics' CNSide To Highlight Clinical Utility Of CNSide Cerebrospinal Fluid Assay Platform For Patients At Risk For Central Nervous System Metastases, At SNO/ASCO CNS Metastases Conference
The Joint Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO) focus on the rapidly evolving area of central nervous system metastasesPresentations will highlight the clinical utility of
07-10 19:37
DoH 与UCSF、IGI合作探索建立全球首个基因组手术中心
阿布扎比医疗保健行业监管机构阿布扎比卫生部（ DoH ）宣布与加州大学旧金山分校（ UCSF ）和创新基因组学研究所（ IGI ）建立合作伙伴关系，探索在阿布扎...
07-07 19:15
Nektar Therapeutics Announces Proposed Public Offering
SAN FRANCISCO, June 30, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of imm...
07-01 04:02
Passage Bio Reports Interim Data From upliFT-D Showing Durable CSF PGRN Elevation And Reduced Plasma NfL Versus Natural History In FTD-GRN
PBFT02 continued to demonstrate robust, durable elevation in CSF PGRN levels and improvement in plasma NfL, a disease progression biomarker, compared to natural historyDose 2, 50% lower than Dose 1, substantially
06-23 19:07
爱迪特获得外观设计专利授权：“烧结炉（CSF-400Pro）”
证券之星消息，根据天眼查APP数据显示爱迪特（301580）新获得一项外观设计专利授权，专利名为“烧结炉（CSF-400Pro）”，专利申请号为CN202430669991.7，授权日为2025年6月10日。
06-10 02:57
VictoryShares US Discovery Enhanced Volatility Wtd ETF declares monthly distribution of $0.0540
VictoryShares US Discovery Enhanced Volatility Wtd ETF (NASDAQ:CSF) - $0.0540. Payable Jul 11; for shareholders of record Jul 09; ex-div Jul 09. More on Victory Portfolios II - VictoryShares US Discov...
2024-07-11 20:29
